<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/132225E8-29CD-4330-8185-C1A2A3699111"><gtr:id>132225E8-29CD-4330-8185-C1A2A3699111</gtr:id><gtr:name>Raigmore Hospital</gtr:name><gtr:address><gtr:line1>Old Perth Road</gtr:line1><gtr:postCode>IV2 3UJ</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0B5C4660-E127-4BC5-A05F-FFEE95EED6F1"><gtr:id>0B5C4660-E127-4BC5-A05F-FFEE95EED6F1</gtr:id><gtr:name>The interNational Early Onset Paediatric IBD Cohort Study (NEOPICS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/73F10E86-681D-4A3F-8193-FD194CB47AC5"><gtr:id>73F10E86-681D-4A3F-8193-FD194CB47AC5</gtr:id><gtr:name>NIHR CRN staff and facilities throughout the UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/41B8ED11-2F70-499F-B830-E858F69FB414"><gtr:id>41B8ED11-2F70-499F-B830-E858F69FB414</gtr:id><gtr:name>?rebro University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Surgical Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/132225E8-29CD-4330-8185-C1A2A3699111"><gtr:id>132225E8-29CD-4330-8185-C1A2A3699111</gtr:id><gtr:name>Raigmore Hospital</gtr:name><gtr:address><gtr:line1>Old Perth Road</gtr:line1><gtr:postCode>IV2 3UJ</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0B5C4660-E127-4BC5-A05F-FFEE95EED6F1"><gtr:id>0B5C4660-E127-4BC5-A05F-FFEE95EED6F1</gtr:id><gtr:name>The interNational Early Onset Paediatric IBD Cohort Study (NEOPICS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/73F10E86-681D-4A3F-8193-FD194CB47AC5"><gtr:id>73F10E86-681D-4A3F-8193-FD194CB47AC5</gtr:id><gtr:name>NIHR CRN staff and facilities throughout the UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/41B8ED11-2F70-499F-B830-E858F69FB414"><gtr:id>41B8ED11-2F70-499F-B830-E858F69FB414</gtr:id><gtr:name>?rebro University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A81109F6-7B27-4E09-A5ED-DE8FCEA82F38"><gtr:id>A81109F6-7B27-4E09-A5ED-DE8FCEA82F38</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:otherNames>Graham</gtr:otherNames><gtr:surname>Dunlop</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/89BA485B-7769-4A31-9B5A-33FC964268AB"><gtr:id>89BA485B-7769-4A31-9B5A-33FC964268AB</gtr:id><gtr:firstName>Jack</gtr:firstName><gtr:surname>Satsangi</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5616E0EF-6C13-4DEC-A430-FD94E45534C7"><gtr:id>5616E0EF-6C13-4DEC-A430-FD94E45534C7</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Prescott</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9F91C63A-FA75-4094-87E1-BA0F9DB65FCD"><gtr:id>9F91C63A-FA75-4094-87E1-BA0F9DB65FCD</gtr:id><gtr:firstName>Craig</gtr:firstName><gtr:surname>Mowat</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/858753BC-51AE-4F60-BD9A-49BE14DA578F"><gtr:id>858753BC-51AE-4F60-BD9A-49BE14DA578F</gtr:id><gtr:firstName>Mhairi</gtr:firstName><gtr:surname>Collie</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F75B2376-AAB2-4A10-9DBA-4F73A0135239"><gtr:id>F75B2376-AAB2-4A10-9DBA-4F73A0135239</gtr:id><gtr:firstName>Ashley</gtr:firstName><gtr:surname>Mowat</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/EC72C7C2-98D0-4ED7-AAE9-467722F4C149"><gtr:id>EC72C7C2-98D0-4ED7-AAE9-467722F4C149</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Arnott</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E2CC6323-E7E7-44B4-9634-080648FFB309"><gtr:id>E2CC6323-E7E7-44B4-9634-080648FFB309</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>C</gtr:otherNames><gtr:surname>Bartolo</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/16B90096-FC48-423E-BBC3-8A92E30396FD"><gtr:id>16B90096-FC48-423E-BBC3-8A92E30396FD</gtr:id><gtr:firstName>Aidan</gtr:firstName><gtr:surname>Cahill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600329"><gtr:id>E85E33A2-4DCF-47EE-A663-670DE8086ED6</gtr:id><gtr:title>Randomised Controlled Trial of 6-Mercaptopurine versus placebo to prevent recurrence of Crohn's disease following surgic</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600329</gtr:grantReference><gtr:abstractText>Crohn s disease is a chronic disabling condition affecting the bowel. Although medical treatment is effective approximately 50% of patient will need an operation to remove an affected segment of bowel over the first 5 years after diagnosis. Recurrence following surgery occurs in the majority of patients. 6-Mercaptopurine is an effective treatment for the reduction of symptoms and maintenance of well being in Crohn s disease but its use to prevent post operative recurrence is poorly defined. Previous studies have been small, retrospective or flawed in design. In this multicentre study we wish to assess the value of the drug 6-mercaptopurine to prevent recurrence of Crohn s disease following surgery. We will use the recurrence of symptoms as the primary outcome measure, with endoscopic examination of the relevant area and the need for further sugery as secondary outcome measures. If this trial were to show an effect of the drug we would anticipate a wide uptake and improved quality of life for patients with Crohn s disease following surgery.</gtr:abstractText><gtr:technicalSummary>This multi-centre double-blind randomised placebo-controlled trial will assess the value of 6-mercaptopurine in preventing recurrence of Crohn?s disease in patients undergoing ileocolonic resection. The primary endpoint is clinical recurrence requiring rescue medical therapy. Secondary endpoints include further surgery. Clinical evaluation will occur every 4 months for 3 years. Colonoscopy at 12 and 36 months (or on relapse) will assess endoscopic evidence of disease recurrence. Faecal calprotectin will be assessed as a marker of early recurrence. TPMT and 6MP metabolite levels with assess the clinical utility of these assays. Genetic and serological data will form part of an exploratory prognostic model.</gtr:technicalSummary><gtr:fund><gtr:end>2019-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1506839</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>?rebro University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>IBD CHARACTER</gtr:description><gtr:id>67C2AF9F-8F61-423A-B862-4076164B03C7</gtr:id><gtr:impact>Biobank established. Data are being generated and publications are anticipated over the next 12 months.</gtr:impact><gtr:outcomeId>aJhmGMubqV2-1</gtr:outcomeId><gtr:partnerContribution>Recruitment and scientific activities.</gtr:partnerContribution><gtr:piContribution>Co-ordinator, recruitment and scientific activities.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The interNational Early Onset Paediatric IBD Cohort Study (NEOPICS)</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>NEOPICS</gtr:description><gtr:id>578B289B-43E2-480A-B63C-5372C9FAECF6</gtr:id><gtr:impact>Multidisciplinary - laboratory, translational and clinical colleagues.

Publication - HH Uhlig, T Schwerd, S Koletzko, N Shah, J Kammermeier, A Elkadri, J Ouahed, DC Wilson, S Travis, D Turner, C Klein, SB Snapper, AM Muise. Very early onset inflammatory bowel disease - diagnostic approach to complex monogenic diseases. Gastroenterology 2014 (in press).

Meeting - participation by Prof DC Wilson at 'VEOIBD 2014' meeting, Toronto, 16/10/14</gtr:impact><gtr:outcomeId>5464c65e28c398.89430129-1</gtr:outcomeId><gtr:partnerContribution>Ongoing genomic, pathway and functional analysis of VEOIBD p[atients.</gtr:partnerContribution><gtr:piContribution>Provision of clinical, phenotypic data and DNA on very-early onset IBD patients (VEOIBD; &amp;lt;10 years old at diagnosis)</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Rowett Institute of Nutrition and Health Aberdeen</gtr:department><gtr:description>Collaboration with Dr Georgina Hold in Aberdeen</gtr:description><gtr:id>42874780-A896-495D-B63E-EB935AEBFFDB</gtr:id><gtr:impact>Work is still underway. At this stage, there is an accepted poster presentation at ECCO, Vienna Feburary 2013, and plans for a paper to be submitted in the next couple of months. There will be further publications and conference abstracts as well.</gtr:impact><gtr:outcomeId>DUNVuyF7tYv-2</gtr:outcomeId><gtr:partnerContribution>Dr Georgina Hold (IMS) and Dr Petra Louis (Rowett) have provided expertise, training and the use of equipment for the studies of the microbiota.</gtr:partnerContribution><gtr:piContribution>We have collected colonic and ileal biopsies over the past 18 months for study of the microbial profile in patients with inflammatory bowel disease and controls. Dr Nick Kennedy has travelled to Aberdeen to extract the DNA from the biopsies and to perform qPCR.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Addenbrooke's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>International IBD genetics consortium</gtr:description><gtr:id>21885FBE-6707-4B08-84AC-D1F8259788A5</gtr:id><gtr:impact>2 publications, further published abstracts:

A Franke, , DPB McGovern, JC Barrett, K Wang, GL Radford-Smith, T Ahmad, CW Lees, T Balschun, J Lee, R Roberts, CA Anderson, JC Bis, S Bumpstead, D Ellinghaus, EM Festen, M Georges, T Green, T Haritunians, L Jostins, A Latiano, CG Mathew, GW Montgomery, NJ Prescott, S Raychaudhuri, JI Rotter, P Schumm, Y Sharma, LA Simms, KD Taylor, D Whiteman, C Wijmenga, RN Baldassano, M Barclay, TM Bayless, S Brand, C B&amp;uuml;ning, A Cohen, J-F Colombel, M Cottone, L Stronati, T Denson, M De Vos, R D'Inca, M Dubinsky, C Edwards, T Florin, D Franchimont, RGearry, J Glas, A Van Gossum, SL Guthery, J Halfvarson, HW Verspaget, J-P Hugot, A Karban, D Laukens, I Lawrance, M Lemann, A Levine, C Libioulle, E Louis, C Mowat, W Newman, J Pan&amp;eacute;s, A Phillips, DD Proctor, M Regueiro, R Russell, P Rutgeerts, J Sanderson, M Sans, FSeibold, AH Steinhart, PCF Stokkers, LTorkvist, G Kullak-Ublick, DC Wilson, T Walters, SR Targan, SR Brant, JD Rioux, M D'Amato, RK Weersma, S Kugathasan, AM Griffiths, JC Mansfield, S Vermeire, RH Duerr, MS Silverberg, J Satsangi, S Schreiber, JH Cho, V Annese, H Hakonarson, MJ Daly, M Parkes. Meta-Analysis Increases to 71 the Tally of Confirmed Crohn's Disease Susceptibility Loci. Nature Genetics 2010; 42: 1118-25 

Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagace C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Buning C, Colombel JF, Denson LA, de Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RSN, Floyd JAB, Florin T, Franchimont D, Franke L, Georges M, Glas J, Glazer NL, Guthery SL, Haritunians T, Hayward NK, Hugot JP, Jobin G, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, McGovern DP, Milla M, Montgomery GW, Morley KI, Mowat C, Ng A, Newman W, Ophoff RA, Papi L, Palmieri O, Peyrin-Biroulet L, Panes J, Phillips A, Prescott NJ, Proctor DD, Roberts R, Russell R, Rutgeerts P, Sanderson J, Sans M, Schumm P, Seibold F, Sharma Y, Simms LA, Seielstad M, Steinhart AH, Targan SR, van den Berg LH, Vatn M, Verspaget H, Walters T, Wijmenga C, Wilson DC, Westra HJ, Xavier RJ, Zhao ZZ, Ponsioen CY, Andersen V, Torkvist L, Gazouli M, Anagnou NP, Karlsen TH, Kupcinskas L, Sventoraityte J, Mansfield JC, Kugathasan S, Silverberg MS, Halfvarson J, Rotter JI, Mathew CG, Griffiths AM, Gearry R, Ahmad T, Brant SR, Chamaillard M, Satsangi J, Cho JH, Schreiber S, Daly MJ, Barrett JC, Parkes M, Annese V, Hakonarson H, Radford-Smith G, Duerr RH, Vermeire S, Weersma RK, Rioux JD. Metaanalysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature Genetics 2011;43: 246-252.</gtr:impact><gtr:outcomeId>11C940B1FC1-1</gtr:outcomeId><gtr:partnerContribution>Data analysis, performance of IBD GWAS, meta-analyses of IBD GWAS, intellectual input</gtr:partnerContribution><gtr:piContribution>Data sharing, intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Investigation of mitochondria DNA as biomarker in IBD</gtr:description><gtr:id>4B5B9352-98BB-47A4-9CC3-3100AC39BE84</gtr:id><gtr:impact>Multidisciplinary basic and clinical research approach to a novel triggering factor in IBD. Potential for new therapy.</gtr:impact><gtr:outcomeId>550c0f17607b83.95833820-1</gtr:outcomeId><gtr:partnerContribution>Technical scientific expertise/</gtr:partnerContribution><gtr:piContribution>Linking human IBD cohort with functional studies of gut mitochondria DNA in inflammation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>IBD BIOM</gtr:description><gtr:id>F346512F-C401-47D7-8B1C-DB215F812091</gtr:id><gtr:impact>Considerable progress has been made in the IBD BIOM Research Programme and new data have been generated, and we anticipate publications over the next 12 months. 
This is the first publication of the IBD BIOM Group:
PMID 24912389.</gtr:impact><gtr:outcomeId>HwYurWhebmi-1</gtr:outcomeId><gtr:partnerContribution>Recruitment and scientific programme.</gtr:partnerContribution><gtr:piContribution>Co-ordinator, lead applicant, recruitment centre and epigenetic discovery programme.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Raigmore Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Colorectal Surgery</gtr:department><gtr:description>Metabolomics colloboration</gtr:description><gtr:id>FC710ED6-8A67-4093-9803-9C0293DE20EF</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>AhsJPRNpdxP-2</gtr:outcomeId><gtr:partnerContribution>Prof Goodacre's lab in Manchester will provide their expertise and the use of their equipment. They will also train Dr Kennedy (Edinburgh) and Dr Hildebrand (Inverness) in the analysis of the metabolomics data.</gtr:partnerContribution><gtr:piContribution>We have collected samples, in collaboration with partners in Inverness, for metabolomics analysis to better understand the metabolomic profile of inflammatory bowel disease.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Paediatric IBD departments</gtr:department><gtr:description>UK and Irish Paediatric IBD genetics group</gtr:description><gtr:id>7D68CA01-3549-4EA5-9919-CD54055F44BA</gtr:id><gtr:impact>First experiment underway - 650 of 720 PICTS DNA samples submitted for international immunochip experiment; data collection commenced in collaborating centres; Analysis underway, 1st abstract published, 1st manuscript submitted 11/2011 to Nature Genetics.</gtr:impact><gtr:outcomeId>VdXmJKskAX5-1</gtr:outcomeId><gtr:partnerContribution>They will widen translational paediatric IBD research from Scotland to 6 selected centres in England plus Dublin, Ireland</gtr:partnerContribution><gtr:piContribution>I am lead of this UK and Irish paediatric IBD genetics group, a new constituent part of the UK IBD genetics consortium, and have attracted external funding as PI to form the paediatric group.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Health Services Research Unit</gtr:department><gtr:description>Collaboration with Dr Georgina Hold in Aberdeen</gtr:description><gtr:id>A43F1F55-A232-4D77-8E3E-5AB213B874EE</gtr:id><gtr:impact>Work is still underway. At this stage, there is an accepted poster presentation at ECCO, Vienna Feburary 2013, and plans for a paper to be submitted in the next couple of months. There will be further publications and conference abstracts as well.</gtr:impact><gtr:outcomeId>DUNVuyF7tYv-1</gtr:outcomeId><gtr:partnerContribution>Dr Georgina Hold (IMS) and Dr Petra Louis (Rowett) have provided expertise, training and the use of equipment for the studies of the microbiota.</gtr:partnerContribution><gtr:piContribution>We have collected colonic and ileal biopsies over the past 18 months for study of the microbial profile in patients with inflammatory bowel disease and controls. Dr Nick Kennedy has travelled to Aberdeen to extract the DNA from the biopsies and to perform qPCR.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Pharmacogenetics Unit Liverpool</gtr:department><gtr:description>ABCB5 function in corticosteroid response in inflammatory bowel disease</gtr:description><gtr:id>C8E8F83F-44A7-41D7-BC93-7B5D9B050AAC</gtr:id><gtr:impact>ABCB5-MEDIATED TRANSPORT OF CORTICOSTEROIDS: A ROLE FOR ABCB5 IN INFLAMMATORY BOWEL DISEASE
Oral abstract presented at the United European Gastroenterology Week 2011. Manuscript preparation in progress.</gtr:impact><gtr:outcomeId>jHmT8cEJN4j-1</gtr:outcomeId><gtr:partnerContribution>Co-application of a successful project grant from National Association of Crohn's and Colitis to study the functional effect of ABCB5 on steroid response - further expanding our unit's expertise in translating genetic to functional work.</gtr:partnerContribution><gtr:piContribution>We made the discovery of 4 genes that predicted the outcomes of corticosteroid response using our patient cohort and have collaborated with the national pharmacogenetics unit to further investigate the functional consequence of the top ranking gene, ABCB5 gene. This work is still in progress but has so far revealed new insight that this gene participates in basolateral transport of corticosteroids in the intestinal epithelium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry Manchester</gtr:department><gtr:description>Metabolomics colloboration</gtr:description><gtr:id>DB9B8514-8DC3-4CC0-A28F-83EDB94DCFBF</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>AhsJPRNpdxP-1</gtr:outcomeId><gtr:partnerContribution>Prof Goodacre's lab in Manchester will provide their expertise and the use of their equipment. They will also train Dr Kennedy (Edinburgh) and Dr Hildebrand (Inverness) in the analysis of the metabolomics data.</gtr:partnerContribution><gtr:piContribution>We have collected samples, in collaboration with partners in Inverness, for metabolomics analysis to better understand the metabolomic profile of inflammatory bowel disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NIHR CRN Staff and Facilities Throughout the UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EXPANSION INTO ENGLAND AND WALES</gtr:description><gtr:id>0C96E28E-74DB-4D0B-9670-110D6AADF8DE</gtr:id><gtr:impact>RESTORATION OF RECRUITMENT RATES TO THOSE EXPECTED.</gtr:impact><gtr:outcomeId>JZoW174pja8-1</gtr:outcomeId><gtr:partnerContribution>RECRUITMENT EXPANSION TO ENGLAND AND WALES.</gtr:partnerContribution><gtr:piContribution>RECRUITMENT EXPANSION INTO ENGLAND AND WALES AS A RESULT OF OUR INVITATION TO 20 OTHER UK CENTRES TO PARTICIPATE</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation to private charity - Cure Crohn's and Colitis organisation.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>57E8C34F-5BB8-4338-8003-4A40D72FAC54</gtr:id><gtr:impact>Presentation to the Cure Crohn's and Colitis (C3) charity board members of current potential translational aspects of genetic work - including pharmacogenetics of corticosteroid response.


This has led to further involvement of C3 in co-funding further work in Edinburgh GI Unit - currently in the development of a national biobank of inflammatory bowel disease in Scotland. Funding of CSO was acknowledged.</gtr:impact><gtr:outcomeId>E9274eLHhYf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CICRA IBD FAMILY INFORMATION DAY</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>327761A5-6CE7-4E6A-A74F-031654732646</gtr:id><gtr:impact>Information given to families.

Increase in patient interest in research.</gtr:impact><gtr:outcomeId>551423a6ef8dc5.57728723</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release of ABCB5 transport as a mechanism of steroid resistance in inflammatory bowel disease.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A7426558-992A-406D-BC91-8DFCB59D29DB</gtr:id><gtr:impact>Following successful funding by National Association of Crohn's and Colitis (NACC) to further study the functional aspects of ABCB5 gene identified by the CSO-funded study, a press release was given - acknowledging the work which led to the discovery of these genes.

The press release achieved wide national dissemination and led to many inquiries from patient groups within/out of the field of inflammatory bowel disease.</gtr:impact><gtr:outcomeId>QNcxqYck9D7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Falk Foundation Gastroenterology Study Day, Birmigham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B72A3EC1-BB61-4C3A-A8BB-9B0316563EF2</gtr:id><gtr:impact>Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2af2f2be568.25528120</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EU IBD-BIOM Meeting in Dubrovnik Croatia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F3DA74D0-3C95-45F1-B38D-CF68AF97D573</gtr:id><gtr:impact>Annual EU BIOM Meeting with collaborators in Europe and elsewhere. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b1044e9480.27099107</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society of Gastroenterology Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0B1642DE-59B7-493C-9E17-3285D9ED2519</gtr:id><gtr:impact>Nil</gtr:impact><gtr:outcomeId>kbQugfnEJ9S</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DDW presentation on Mercaptopurine following Azathioprine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A1E37B73-A12A-480D-837E-B3CB4F5294D0</gtr:id><gtr:impact>Well-attended oral presentation at DDW May 2012, San Diego (www.ddw.org).
Rhatigan EB, Kennedy NA, Arnott ID, Noble CL, Shand AG, Satsangi J, Lees CW. A Trial With Mercaptopurine Following Azathioprine Intolerance is a Safe Treatment Strategy for the Majority of Patients With IBD. DDW 2012. (Presentation prepared and given by Dr Kennedy.) Gastroenterology 2012;142:S-206.



Paper underway and will be submitted soon.</gtr:impact><gtr:outcomeId>QAe4yRwHhSz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Digestive Disease Week San Diego, California, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>70DE30F3-D06B-4EC0-AAD1-97F2AAA63DDE</gtr:id><gtr:impact>Presentation given at Digestive Disease Week, American Gastroenterology Association. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b3077feac7.41568044</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to a charity C3</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DE11D210-F3C8-4D45-A4AB-EA9FA05D9ECF</gtr:id><gtr:impact>Board meeting attended by approx 10 people. Dr Kennedy presented his research to date which provoked interested discussion.

Expression of interest for possible further funding.</gtr:impact><gtr:outcomeId>JDLQETkcaVN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society of Gastroenterology Meeting in Liverpool</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8E85D65E-1BF8-4932-9348-F3C74D67787E</gtr:id><gtr:impact>Giving a talk at the annual British Society of Gastroenterology Meeting. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b809dd2da3.10820942</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EU IBD Character Meeting Barcelona Spain</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>32EADAEB-08F5-476C-9013-6C328BF8B3DA</gtr:id><gtr:impact>Annual Meeting with collaborators throughout Europe and elsewhere. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b96d4fd839.82211780</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NACC LECTURES</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FC52F5D0-081C-43C2-8FA7-8360C1B8FE8B</gtr:id><gtr:impact>HEIGHTENED INTEREST AND AWARENESS OF ON-GOING RESEARCH WORK IN CROHN'S DISEASE

MEDIA INTEREST FOLLOWED.</gtr:impact><gtr:outcomeId>eY9pWtNSgRE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to UEGW on Thiopurine Withdrawal</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1042B708-9851-4A3F-B87E-04D70C309ECD</gtr:id><gtr:impact>UEGW, Stockholm 2011. Well-attended oral presentation.

Kennedy NA, Gambles CJ, Musy RM, Jones GR, Arnott ID, Satsangi J, Lees CW. Predictive Factors of Disease Relapse Following Thiopurine Withdrawal for Sustained Clinical Remission of IBD.

We have subsequently presented this data at a British meeting and have extended the study to include other British sites. A paper is in progress.</gtr:impact><gtr:outcomeId>KvkfiXhC8Wh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>20th Advanced Gastroenterology &amp; Hepatology Course, Royal College of Physicians of Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>93A7BD76-01A1-4D8A-82BD-91F7936650EF</gtr:id><gtr:impact>Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2ad5a3bdc73.06353875</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to CCUK Charity April 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8601F32C-BFB1-48F3-B881-0011CB3A418E</gtr:id><gtr:impact>200 delegates. Very positive feedback.

Nil</gtr:impact><gtr:outcomeId>ATqpN8vRtZR</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society of Gastroenterology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B47913E5-8345-43BC-BC55-AEC064241219</gtr:id><gtr:impact>Discussion was stimulated.

Further research projects proposed.</gtr:impact><gtr:outcomeId>5460ee45a683a4.32230764</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University of Edinburgh Centre for Inflammation Research Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B7209ADE-1651-4554-8E65-78A3A9666463</gtr:id><gtr:impact>University of Edinburgh Internal Lecture. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b206a386f5.54564972</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Falk IBD Meeting Birmingham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>412780AC-EE59-46D8-802E-085BF3433D84</gtr:id><gtr:impact>Dr Falk Meeting 2016 - Disseminaton of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b9dc49adc4.14929342</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Masterclass 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0B8C3EEA-F341-44A6-AF64-2E6D0D2D0D7C</gtr:id><gtr:impact>Giving talk at Oxford Masterclass Meeting - dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b8b5d16869.16779304</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Guest Speaker University of Cork</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A914687F-09D4-46CB-84D3-939B46FE9D55</gtr:id><gtr:impact>Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2c1f52d0ed8.66990843</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UNIVERSITY OF EDINBURGH, PUBLIC LECTURE, QUEENS MEDICAL RESEARCH INSTITUTE</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>63A1C380-8315-4E9D-A115-BC1DE063B6AB</gtr:id><gtr:impact>Dissemination of scientific knowledge and advances in patient care, to general public, clinicians, scientists.</gtr:impact><gtr:outcomeId>58c2c14c0420b7.14176393</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Symposium EU Project Forum, Amsterdam, Netherlands</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C89C8098-9959-4915-B7F3-9F047D76A802</gtr:id><gtr:impact>Collaborative Meeting for EU Collaborators during ECCO Amsterdam meeting. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b05496dda4.84416639</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Swedish Gastrodagarna</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D5D860B5-40DB-4EDD-85C7-3BD730E0B42A</gtr:id><gtr:impact>Lecture given to conference in Orebo, Sweden, on 30 May 2013.

Nil</gtr:impact><gtr:outcomeId>d1G1Vh2G22Q</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP 7 EC IBD BIOM GRANT</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>305479-2</gtr:fundingRef><gtr:id>A9D3F180-7404-401D-94B2-163B70B4A0C8</gtr:id><gtr:outcomeId>h6FyB2kHV2r</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2738767</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CLINICAL TRIALS GRANT</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0600329</gtr:fundingRef><gtr:id>CC227082-224C-45FE-95F6-0CDC1812C9C7</gtr:id><gtr:outcomeId>ZL7BzUJE6Ex0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5975589</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Horizon 2020 - Research and Innovation Framework Programme</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>PHC-13-2014</gtr:fundingRef><gtr:id>3D48AD8B-780A-4128-9095-8FBBF6E41D3E</gtr:id><gtr:outcomeId>5515362aac4e30.83818928</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>251648</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Clinical Research Training Fellowship</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>09743/Z/11/Z</gtr:fundingRef><gtr:id>2FAB4433-620C-4955-8B63-F4F792A847B9</gtr:id><gtr:outcomeId>N1hvWiYohWb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Edinburgh GI Trustees</gtr:description><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>522A6D91-2C9F-41C5-BE93-114A66CE6F99</gtr:id><gtr:outcomeId>550c0e098c54c7.85763277</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>647570</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR BioResource</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M00533X/1 Parkes</gtr:fundingRef><gtr:id>9AF2A65A-03D5-4E48-AD12-06EDC7B8E727</gtr:id><gtr:outcomeId>55153520148af3.28366646</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5975589</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>New Therapies for chronic non-communicable diseases - BIOCYLE</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>66FFE6F4-8F88-4CC2-B269-92938B4E69EA</gtr:id><gtr:outcomeId>56d70e64f41235.09555492</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Association of Crohn's and Colitis Project Grant</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>National Association for Colitis and Crohn?s Disease (NACC)</gtr:fundingOrg><gtr:id>5F817AD6-A5CF-4C74-9164-B4B3AE5E49C4</gtr:id><gtr:outcomeId>ZdVwCZRKydU0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>224998</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant Application</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:fundingRef>ETM/395</gtr:fundingRef><gtr:id>66C00C0D-FA6C-4E5E-B005-8C3AF6A32BAF</gtr:id><gtr:outcomeId>55153860d32a47.50379632</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP7 EC IBD CHARACTER</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>305676-2</gtr:fundingRef><gtr:id>DFC18D67-CEAA-4726-994D-492A57A2CBC0</gtr:id><gtr:outcomeId>d2UXTjnoB6x</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>257684</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CSO PROJECT GRANT SUPPORT - EXPERIMENTAL &amp;amp; TRANSLATIONAL MEDCINE BOARD</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:fundingRef>ETM/137</gtr:fundingRef><gtr:id>FA8FF551-E61D-423F-B3D2-DE3501E36373</gtr:id><gtr:outcomeId>rbusLBvpbs50</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99638</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MicroRNA profiling in Inflammatory Bowel Diseases: The application of Next Generation Sequencing</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Crohn's and Colitis UK</gtr:fundingOrg><gtr:id>D161D7F8-17CA-4676-9373-9854987AA73E</gtr:id><gtr:outcomeId>58c298d32fef73.81206161</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BRITISH SOCIETY OF GASTROENTEROLOGY IBD GUIDELINES</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FB3F0698-451C-4A49-B383-DBA02AEEF8B1</gtr:id><gtr:outcomeId>kjQBYrVoUSn</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have compiled the largest database of corticosteroid response in newly diagnosed patients with IBD across a 13-year period in Lothian.</gtr:description><gtr:id>91CA42F6-55C0-473E-86CB-E7BCB8522447</gtr:id><gtr:impact>Further clinical studies to longitudinally study the clinical outcomes of this cohort have been performed and results presented in national and international meetings.</gtr:impact><gtr:outcomeId>RAoGJdwBZba</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Database of 13-year inception cohort of corticosteroid outcome in IBD.</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Phenotyping of paediatric IBD with relation to response outcomes to corticosteroids. The objective is to study pharmacogenetic contribution of ABCB5 gene to this clinical end-point.</gtr:description><gtr:id>EEEE238F-9CCB-48FB-BBC8-A1A62F98139D</gtr:id><gtr:impact>Still in progress.</gtr:impact><gtr:outcomeId>axDiPngEyEM</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Paediatric IBD Scottish Cohort</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CC4EA4C0-F94E-4403-BB52-64E9847B3D42</gtr:id><gtr:title>Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>The Journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9eeda35358bcc4dfe61af28779ec9474"><gtr:id>9eeda35358bcc4dfe61af28779ec9474</gtr:id><gtr:otherNames>Barclay AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3476</gtr:issn><gtr:outcomeId>CQ9fRzksXgm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69DA00E0-44AE-4010-B2A2-66231840FE7E</gtr:id><gtr:title>Sarcoidosis complicating treatment with natalizumab for Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bffe2c88e0743de298720c2901b77790"><gtr:id>bffe2c88e0743de298720c2901b77790</gtr:id><gtr:otherNames>Parisinos CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>UsakmkjgTXx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC52919C-E2CA-41B8-9456-47A0FAC44EBD</gtr:id><gtr:title>Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67c4802bef8cffec7e1326194d07eaa1"><gtr:id>67c4802bef8cffec7e1326194d07eaa1</gtr:id><gtr:otherNames>Jostins L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15892_22_23128233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A89D83A-B66D-4086-8275-1100C8F74E41</gtr:id><gtr:title>Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>545a388dc1a454.19385979</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5217E804-89A5-4F8B-BC43-B34D1CCD2899</gtr:id><gtr:title>Germline variants of IRGM in childhood-onset Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>54648b3d03a6f4.83739994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2156E8C6-7990-4258-A1AD-C7BAB5F98CFE</gtr:id><gtr:title>Biomarkers in Search of Precision Medicine in IBD.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>58b95f2c026cf6.54458369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E3BF073-0696-457B-9CF7-2346CA5C71A7</gtr:id><gtr:title>Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapy.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>551048425e1302.54749176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>025E71E5-8066-42C2-A9DF-3E8AA54F45A7</gtr:id><gtr:title>Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c601a805f173a4991f1b619667ca44c2"><gtr:id>c601a805f173a4991f1b619667ca44c2</gtr:id><gtr:otherNames>Dehghan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>QhstBYADDqk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A4E4505-CE7C-4B65-8CB9-ADF4A856614F</gtr:id><gtr:title>Editorial: Early corticosteroids in ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>545a39ef2cf781.94320924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB737397-A9C2-4F5D-8D21-63DD75598343</gtr:id><gtr:title>Rising incidence of pediatric inflammatory bowel disease in Scotland.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>545a52de5ef402.34204530</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C9D7E37-ED55-4306-82C8-77658FD53C27</gtr:id><gtr:title>Seven newly identified loci for autoimmune thyroid disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/944c80fb10c6590f6168fa3c3cf2c8c1"><gtr:id>944c80fb10c6590f6168fa3c3cf2c8c1</gtr:id><gtr:otherNames>Cooper JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_15892_22_22922229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A244A65-CFFE-4C07-8BE1-8F52A7821D0D</gtr:id><gtr:title>Systematic meta-analyses and field synopsis of genetic and epigenetic studies in paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93f8556619f3487d06c35513ec7d86fb"><gtr:id>93f8556619f3487d06c35513ec7d86fb</gtr:id><gtr:otherNames>Li X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b95f2bb9b2e7.44500489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEBBD75A-FA7F-4809-B65D-E4B09E402C82</gtr:id><gtr:title>Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b62e0c846f35d4fdfa1e6d3c1bc9e68"><gtr:id>2b62e0c846f35d4fdfa1e6d3c1bc9e68</gtr:id><gtr:otherNames>Aloi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>585d676f466640.81831097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47205BAC-B302-40A9-A8A0-9878BC2E85C4</gtr:id><gtr:title>Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1396e262f01d61d4d04461debba360"><gtr:id>3c1396e262f01d61d4d04461debba360</gtr:id><gtr:otherNames>Andersen V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>Rurfy2dphrC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA6F4A8E-7369-4777-ADFD-44395C048927</gtr:id><gtr:title>Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bd098697bd70f44f21e158259d0b6f4"><gtr:id>1bd098697bd70f44f21e158259d0b6f4</gtr:id><gtr:otherNames>Rivas MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>545a4662eaeaa4.40819847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C0A9916-FB80-4F54-AD1B-F6A2349529E9</gtr:id><gtr:title>Genes in inflammatory bowel disease: lessons from complex diseases.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>54637ae9261e65.57579973</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5A4ECC4-DDFF-4114-AF70-EB9CBBE069DC</gtr:id><gtr:title>Advances in IBD genetics.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-5045</gtr:issn><gtr:outcomeId>545a3b484ade24.77967959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BF8E438-D880-49E7-96A5-2A0A8E5334B4</gtr:id><gtr:title>Changes to serum sample tube and processing methodology does not cause Intra-Individual [corrected] variation in automated whole serum N-glycan profiling in health and disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b95f2fdc86e1.37722175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>244899E4-BC34-462F-9195-D99141AC82D2</gtr:id><gtr:title>Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>oBm23VbrLMC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5A251F7-6586-4FF3-B05C-61919242AC88</gtr:id><gtr:title>Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c5db92b3cd994f383d1bd62191511d"><gtr:id>90c5db92b3cd994f383d1bd62191511d</gtr:id><gtr:otherNames>Cross-Disorder Group of the Psychiatric Genomics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b987834b59e0.03036160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47605B4E-ED6C-4568-8B83-9461D13B0E6E</gtr:id><gtr:title>Pathogenesis of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>F1000prime reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d303a6716833659b362d79806b3d7355"><gtr:id>d303a6716833659b362d79806b3d7355</gtr:id><gtr:otherNames>Boyapati R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-7599</gtr:issn><gtr:outcomeId>56d5925b5ccb62.11605424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A949B7F-CC41-4C0F-A93E-56191D986E55</gtr:id><gtr:title>Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7df3307e11c9bb132b88045342e68068"><gtr:id>7df3307e11c9bb132b88045342e68068</gtr:id><gtr:otherNames>Ruark E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15892_22_23242139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE9D6EED-2807-45A8-96BD-90B1397ADC81</gtr:id><gtr:title>Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee2f00367823c286d1309d18b6f74ea2"><gtr:id>ee2f00367823c286d1309d18b6f74ea2</gtr:id><gtr:otherNames>Trbojevic Akmacic I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>56d59285c8e304.79794692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B0DB65E-FFFC-48AF-9CD2-0129F1E383C7</gtr:id><gtr:title>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>UyQWDXLRk4W</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>773BB633-F6A8-4213-BB20-E7E9DAB13646</gtr:id><gtr:title>Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc1be9d73443472df126223161b1632b"><gtr:id>cc1be9d73443472df126223161b1632b</gtr:id><gtr:otherNames>Ban M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>54648b6c03aa95.02966683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80AC5325-B462-478C-973F-9A461C53D26D</gtr:id><gtr:title>Correction: changes to serum sample tube and processing methodology does not cause inter-individual variation in automated whole serum N-glycan profiling in health and disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b95f2f4c7bb1.33080033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74AFFF83-2673-472E-9C11-9BFD8688FBB2</gtr:id><gtr:title>NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7db1b373f7864413af24edeb44e89bed"><gtr:id>7db1b373f7864413af24edeb44e89bed</gtr:id><gtr:otherNames>Schwerd T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5a8e8fa4042559.49169605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>609A4CDE-93A0-4361-A140-1DC7C4CE8DAF</gtr:id><gtr:title>Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40332de4193aa1266d1b40d478d98ba7"><gtr:id>40332de4193aa1266d1b40d478d98ba7</gtr:id><gtr:otherNames>Adams A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>5a8e8f5a230d03.85643658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>393D5EF4-CB4C-4996-B0E6-1E87CAECAC3E</gtr:id><gtr:title>Filaggrin loss-of-function variants are associated with atopic comorbidity in pediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>54648b044b89d9.48366175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA606C7E-87E2-4160-9164-9569425E04B5</gtr:id><gtr:title>Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c83ed689c5a5ce62539b156194e47f43"><gtr:id>c83ed689c5a5ce62539b156194e47f43</gtr:id><gtr:otherNames>Reilly MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>Ni7cU9suXYP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20FA0348-24C6-425A-A247-AA98F9F1A101</gtr:id><gtr:title>Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a8e92198e5c96.65334105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1784535A-D6CF-438E-B639-0CF557028DAE</gtr:id><gtr:title>Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8e45c11ff8b196523502e41d8ce46cf"><gtr:id>c8e45c11ff8b196523502e41d8ce46cf</gtr:id><gtr:otherNames>Anderson CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>N6z2etrz5iU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97E05E18-609A-4C8D-93F0-44C710D61803</gtr:id><gtr:title>Genetic sharing and heritability of paediatric age of onset autoimmune diseases.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1605ad728ecb6d5cabf79b7add99fc60"><gtr:id>1605ad728ecb6d5cabf79b7add99fc60</gtr:id><gtr:otherNames>Li YR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56d5917cb72e78.72259304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB954902-439F-48A3-996D-0053F74B76DE</gtr:id><gtr:title>High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f44301104351bc4e4ca5a598859ccee4"><gtr:id>f44301104351bc4e4ca5a598859ccee4</gtr:id><gtr:otherNames>Goyette P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5510486e10b719.60547980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64A2F227-D4D9-4E74-B100-D6763C5EA243</gtr:id><gtr:title>Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b98783bd4a65.18936381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DE803E2-15A7-4AE7-B0D9-7CF2FD9F7365</gtr:id><gtr:title>Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58e9b7843c867fa71473bb98977691f6"><gtr:id>58e9b7843c867fa71473bb98977691f6</gtr:id><gtr:otherNames>Russell RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>54648c062f1125.25759238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55144968-7AEC-4B0F-8438-1F637845DF29</gtr:id><gtr:title>Meta-analysis and imputation refines the association of 15q25 with smoking quantity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>MrXP8LbMej3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B61E76D-A53E-4E46-A65E-D04DC36241E2</gtr:id><gtr:title>Negligible impact of rare autoimmune-locus coding-region variants on missing heritability.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d5e44cfd0fb461260062e89bab9868"><gtr:id>28d5e44cfd0fb461260062e89bab9868</gtr:id><gtr:otherNames>Hunt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15892_22_23698362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45213C31-2306-4A60-8852-4257478397F3</gtr:id><gtr:title>NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52c5be27aaf2a70d86136ab7214ebf96"><gtr:id>52c5be27aaf2a70d86136ab7214ebf96</gtr:id><gtr:otherNames>Muise AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>545a46c09ad004.52449282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF6B86E8-B0E4-48ED-9DAB-9570F2F2912F</gtr:id><gtr:title>Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d5e44cfd0fb461260062e89bab9868"><gtr:id>28d5e44cfd0fb461260062e89bab9868</gtr:id><gtr:otherNames>Hunt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15892_22_22200769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DCFCE07C-B040-4BD8-91D6-212567C367D0</gtr:id><gtr:title>Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c48199838cc2f29a1eac9e5f8f6b0422"><gtr:id>c48199838cc2f29a1eac9e5f8f6b0422</gtr:id><gtr:otherNames>Grozeva D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>KkCJE7YYw7b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7CED5A9-C2F1-423D-AE3D-698FF6CC1656</gtr:id><gtr:title>The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>pm_15892_22_22370604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E59BA461-75C9-4046-AD55-F1388515AC93</gtr:id><gtr:title>A common biological basis of obesity and nicotine addiction.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60115f8ea005e2a184f16c4d64088d52"><gtr:id>60115f8ea005e2a184f16c4d64088d52</gtr:id><gtr:otherNames>Thorgeirsson TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>545a3c2e3f1d06.17321649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B434C16-A4E0-49EA-82C8-6A07D53D82F6</gtr:id><gtr:title>Systematic review: The use of thiopurines or anti-TNF in post-operative Crohn's disease maintenance--progress and prospects.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc5db65cb0365641c12089dcf2c6679e"><gtr:id>cc5db65cb0365641c12089dcf2c6679e</gtr:id><gtr:otherNames>Jones GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>545a3ac6873c19.13605249</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E2CD850-0725-47BB-AC6E-65FE139AC0AF</gtr:id><gtr:title>Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61679ec8c97393a31d71ea64b48eb8c7"><gtr:id>61679ec8c97393a31d71ea64b48eb8c7</gtr:id><gtr:otherNames>Torres J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>56d591b51958b1.93000793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>413BDAC9-6082-43B0-A6E0-F170C78F4B61</gtr:id><gtr:title>The genetics of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Annual review of genomics and human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1527-8204</gtr:issn><gtr:outcomeId>546385bc39fa94.92183360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2E3509C-A9BC-4FBB-B4B5-75FA14EC6EF9</gtr:id><gtr:title>Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f5948b5a7f162e349b3184da5420ba0"><gtr:id>5f5948b5a7f162e349b3184da5420ba0</gtr:id><gtr:otherNames>Wang K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>54648bb9c704b0.35731607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DACF2D4D-14D9-4027-8C68-446F887FB6CD</gtr:id><gtr:title>Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52c5be27aaf2a70d86136ab7214ebf96"><gtr:id>52c5be27aaf2a70d86136ab7214ebf96</gtr:id><gtr:otherNames>Muise AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>BFwhQib4RKv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B4414CC-B4BC-4330-AE06-96D067ED1335</gtr:id><gtr:title>Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>WQRtXHaygi2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80F4E911-43A0-4694-BDDC-7B4DDB744D5B</gtr:id><gtr:title>The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>Q89Qmm4RUEy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98ADEDEF-36A6-4D24-A47A-62C927BEE196</gtr:id><gtr:title>Haplotype-tagging analysis of common variants of the IL23R gene demonstrates gene-wide extent of association with IBD.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>pm_15892_22_23535247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3834C141-D559-44BE-A135-B937DCB1A4DF</gtr:id><gtr:title>Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/886606afd4f9c4c3637aefb0a28e1750"><gtr:id>886606afd4f9c4c3637aefb0a28e1750</gtr:id><gtr:otherNames>Ross SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>pm_16612_22_21822149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>625F3DFF-7124-4949-9A21-D790366F6422</gtr:id><gtr:title>Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>pm_15892_22_23751777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F849054-DB84-4336-8064-F99F1E6EF01E</gtr:id><gtr:title>Detailed haplotype-tagging study of germline variation of MUC19 in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c03c031f93314568064c52c650a9dae9"><gtr:id>c03c031f93314568064c52c650a9dae9</gtr:id><gtr:otherNames>Phillips AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>pKTBbsdGKGu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C38FB31-32F3-4777-80C7-A383F351022A</gtr:id><gtr:title>Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>58c132fae3bd01.51152525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98C2E6CD-F617-4A94-9731-1D7F654C30D4</gtr:id><gtr:title>Differences in the integrase and reverse transcriptase transmitted resistance patterns in Northern Poland.</gtr:title><gtr:parentPublicationTitle>Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2c4aab0d4afcc3e208206d4ba1780f8"><gtr:id>d2c4aab0d4afcc3e208206d4ba1780f8</gtr:id><gtr:otherNames>Parczewski M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1567-1348</gtr:issn><gtr:outcomeId>58b95f2ab0be53.90572890</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A55592E-E0C3-45C8-AF35-2795F92E3FD0</gtr:id><gtr:title>HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fb8b35143d2c3224157d16285969e98"><gtr:id>4fb8b35143d2c3224157d16285969e98</gtr:id><gtr:otherNames>Heap GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>545a3952b8b943.68422211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65D1E79E-8094-4C4E-8762-4E028705727E</gtr:id><gtr:title>The intermediate filament protein, vimentin, is a regulator of NOD2 activity.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e44fcfb9fb3237b0ce7a55d7295b2a46"><gtr:id>e44fcfb9fb3237b0ce7a55d7295b2a46</gtr:id><gtr:otherNames>Stevens C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>pm_15892_22_22684479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>121B9F39-C35C-4ECD-A9BA-7F299B5C075F</gtr:id><gtr:title>Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5b403a7f6ad6f739fef6c9fb0b8f1fd"><gtr:id>d5b403a7f6ad6f739fef6c9fb0b8f1fd</gtr:id><gtr:otherNames>Luo Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b95f2aed3475.31291029</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F872E70-9063-4AAE-9000-42A200FBCCD6</gtr:id><gtr:title>Growth in children receiving contemporary disease specific therapy for Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff310746e9ace20777a8783a2e3393dd"><gtr:id>ff310746e9ace20777a8783a2e3393dd</gtr:id><gtr:otherNames>Malik S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>pm_16612_22_22685044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6218A3EF-07F0-409E-8F64-3CA7C7BC05CF</gtr:id><gtr:title>Editorial: what can be done when infliximab stops working in ulcerative colitis?</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>58c132fb362a60.69731705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8571D18A-764E-4BAF-8328-32C575C7461D</gtr:id><gtr:title>A role for vimentin in Crohn disease.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_15892_22_22929019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0E1CF5C-BEBB-4E2E-8410-7A5FA6A1A45F</gtr:id><gtr:title>Lack of association between cervical dysplasia and IBD: a large case-control study.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>VtsVJkzf7qn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>479C1254-06D1-4D56-86A7-DE8BA1EAAF5C</gtr:id><gtr:title>Early combined immunosuppression in Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>546490db4a52c3.99229286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D246412-B253-454B-9920-A1C328DD724B</gtr:id><gtr:title>What do the terms &amp;quot;genetic predisposition&amp;quot; and &amp;quot;genetic heterogeneity&amp;quot; mean in relation to inflammatory bowel disease?</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da24c4aa9fd3d3f04a822291d0cbde0"><gtr:id>5da24c4aa9fd3d3f04a822291d0cbde0</gtr:id><gtr:otherNames>Satsangi J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>54648db02792d3.16457880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78F5132F-CD23-4FE7-BA06-AE2167370089</gtr:id><gtr:title>TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8ba377304d5e7fd1f2b7d997300293a"><gtr:id>c8ba377304d5e7fd1f2b7d997300293a</gtr:id><gtr:otherNames>Nimmo ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>545a529824ae66.24153503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D140A424-E2F3-4381-96ED-6E0D434544FE</gtr:id><gtr:title>Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohn's disease: an observational, retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bffe2c88e0743de298720c2901b77790"><gtr:id>bffe2c88e0743de298720c2901b77790</gtr:id><gtr:otherNames>Parisinos CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>Z5yfgFf3n1f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C63921F0-7722-48A8-8A8D-DDE9FB8549F7</gtr:id><gtr:title>Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>pm_15892_22_22221081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B214E0F6-F013-4EE4-8763-6A755A72029A</gtr:id><gtr:title>Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history.</gtr:title><gtr:parentPublicationTitle>Expert review of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1747-4124</gtr:issn><gtr:outcomeId>PqgaULSxffD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B678AD7B-772D-443B-8F28-C5F82344F210</gtr:id><gtr:title>Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e2d0947beef3a4da746fc9d89cbb670"><gtr:id>0e2d0947beef3a4da746fc9d89cbb670</gtr:id><gtr:otherNames>Turner D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5464c21c2ae6c3.05485653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AC04855-AEB7-43FB-BF8F-FBDAB4EE84DE</gtr:id><gtr:title>Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b004e39d62a9fcb4cc88a22083af34fa"><gtr:id>b004e39d62a9fcb4cc88a22083af34fa</gtr:id><gtr:otherNames>International Multiple Sclerosis Genetics Consortium (IMSGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56e17613414cd8.36193009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6BE5CFE-0944-4A6A-BC1E-40B7CD3AF487</gtr:id><gtr:title>Fine-mapping inflammatory bowel disease loci to single-variant resolution.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e94754791b4be0de589dc01808c98d92"><gtr:id>e94754791b4be0de589dc01808c98d92</gtr:id><gtr:otherNames>Huang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a8e9092769757.26209491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CFD61F3-B568-4B99-9D9C-90703F84EE0E</gtr:id><gtr:title>Detailed assessment of NOD2/CARD15 exonic variation in inflammatory bowel disease in Scotland: implications for disease pathogenesis.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58e9b7843c867fa71473bb98977691f6"><gtr:id>58e9b7843c867fa71473bb98977691f6</gtr:id><gtr:otherNames>Russell RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>5464906b594d71.89579020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>519063AB-6F56-4008-B3CF-AC20D11C3C46</gtr:id><gtr:title>Genome-wide and fine-resolution association analysis of malaria in West Africa.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>bWdSFdEN5PP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E13BEE9B-EF94-4B88-A62E-B5F7EDE42ED7</gtr:id><gtr:title>Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f5948b5a7f162e349b3184da5420ba0"><gtr:id>5f5948b5a7f162e349b3184da5420ba0</gtr:id><gtr:otherNames>Wang K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>VYKxNnLQqCX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C062E41-F083-46D4-942D-A34727FB7F20</gtr:id><gtr:title>Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>545a39ab9c78a4.95440171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8CBDB42-7454-4902-BECC-3E21FD66291F</gtr:id><gtr:title>Anti-TNF therapy for paediatric IBD: the Scottish national experience.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c5840b49afd918f3f3f911a699aa139"><gtr:id>1c5840b49afd918f3f3f911a699aa139</gtr:id><gtr:otherNames>Cameron FL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>doi_55f984984bd46761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D576EA50-C1F5-4A2C-9627-4614EE54B470</gtr:id><gtr:title>High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/906af871a1f703f6246584282b1313b8"><gtr:id>906af871a1f703f6246584282b1313b8</gtr:id><gtr:otherNames>Eyre S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15892_22_23143596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B7B39AE-3F29-4B38-9A49-B21CC28F53AE</gtr:id><gtr:title>Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546b1e0b1339f37380d709047c712095"><gtr:id>546b1e0b1339f37380d709047c712095</gtr:id><gtr:otherNames>Barrett JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>D4cb4VWDpaN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>085C206D-548A-4575-A291-6DD7524A42D3</gtr:id><gtr:title>Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f464f9e14d797f32cb291cb1c8e1802b"><gtr:id>f464f9e14d797f32cb291cb1c8e1802b</gtr:id><gtr:otherNames>Aldhous MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5463846a661bb8.36745166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F01F8D1D-583D-41B8-A38A-7D631083CE29</gtr:id><gtr:title>Management of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b83a9614183474a838d8cd9ab297f54"><gtr:id>9b83a9614183474a838d8cd9ab297f54</gtr:id><gtr:otherNames>Kammermeier J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>585d55c44d4b87.01895834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D8A22AA-8A4F-411D-BEFA-8DA0194A5E03</gtr:id><gtr:title>Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a31994e93582d0033292b37419bb3c5"><gtr:id>5a31994e93582d0033292b37419bb3c5</gtr:id><gtr:otherNames>Hawkey CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>56d591072b9aa5.82876438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>147E2795-EA51-42C0-93F0-AB226F60CBC8</gtr:id><gtr:title>Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43d0d23737bcf164813e93f774577d3e"><gtr:id>43d0d23737bcf164813e93f774577d3e</gtr:id><gtr:otherNames>UK IBD Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>beJZ58q5Qjj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C154F7F8-E256-448C-B31D-85E0D6DD28D6</gtr:id><gtr:title>Paneth cell marker CD24 in NOD2 knockout organoids and in inflammatory bowel disease (IBD).</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>pm_15892_22_23704317</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1BDD810-5286-49AC-AB9F-F900C50DA937</gtr:id><gtr:title>Genome-wide association study identifies eight loci associated with blood pressure.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15b00f9f5513473e8bd79455323c1869"><gtr:id>15b00f9f5513473e8bd79455323c1869</gtr:id><gtr:otherNames>Newton-Cheh C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>i65KQEkNbTC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD33B6CC-19B6-4EE0-8C3A-AF06E6D6A49C</gtr:id><gtr:title>Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56d5922a2ea727.13635506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>914BEB6F-4A48-4351-B9A0-29A4E9F1F1C3</gtr:id><gtr:title>The changing epidemiology of paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>XTSsJNDsyCu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>270278A9-0B58-4C04-A827-B57210A9130D</gtr:id><gtr:title>Contemporary outcomes for ulcerative colitis inpatients admitted to pediatric hospitals in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58e9b7843c867fa71473bb98977691f6"><gtr:id>58e9b7843c867fa71473bb98977691f6</gtr:id><gtr:otherNames>Russell RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>56e1772572c909.43076876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9321E5C-1905-43C6-B41D-ECC2FF234E55</gtr:id><gtr:title>Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e051e9782b413d28b51dac97e8d57905"><gtr:id>e051e9782b413d28b51dac97e8d57905</gtr:id><gtr:otherNames>Rossin EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>q5MYtgvmNDd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CA791C0-AF76-4D75-89BE-395F3E0C8B5B</gtr:id><gtr:title>Management of ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44825b63f5849da32252d083e4f88ab5"><gtr:id>44825b63f5849da32252d083e4f88ab5</gtr:id><gtr:otherNames>Fell JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>585d55c0cfcfb1.70806862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBB664E1-666B-425E-A868-32FBD84949A1</gtr:id><gtr:title>Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>JAR41cJCm2Q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C999670A-D7F0-4B75-9F70-765009037005</gtr:id><gtr:title>Bayesian refinement of association signals for 14 loci in 3 common diseases.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15892_22_23104008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B4D489D-7B20-4593-9311-7878D9D80E44</gtr:id><gtr:title>Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eceaa0d8d49922665570d609c2586922"><gtr:id>eceaa0d8d49922665570d609c2586922</gtr:id><gtr:otherNames>Villani AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>eA23k547AvY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F353B003-87C1-47E1-AFE5-C4C4DDEE5677</gtr:id><gtr:title>Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>54648e55079dd7.66202065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52099970-E9D9-4019-97C0-4241EB8B9620</gtr:id><gtr:title>Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (2004-2008).</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f42b266fd11aa87e2c88a384ee9d26"><gtr:id>64f42b266fd11aa87e2c88a384ee9d26</gtr:id><gtr:otherNames>Ho GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>54648bdd6cea12.43657137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB5BE8E8-4F74-49AA-B852-2A4E33BE6C48</gtr:id><gtr:title>Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>pm_15892_22_22070187</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CFEB9BF-F7BB-417D-B406-14608E58F0F0</gtr:id><gtr:title>Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445a6cbea1ff0c3d67d561dda89695ca"><gtr:id>445a6cbea1ff0c3d67d561dda89695ca</gtr:id><gtr:otherNames>Prescott NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>551047ab4a6d67.15727692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2028DC0C-C164-4A4B-A858-E8A45874BD3B</gtr:id><gtr:title>Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a255a9d973fc3e59f2dbd0ef03280b76"><gtr:id>a255a9d973fc3e59f2dbd0ef03280b76</gtr:id><gtr:otherNames>Franke A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>J7DHfkYqBCx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D27D6FA9-09BB-400F-8426-EB4B01F2A9E1</gtr:id><gtr:title>PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd29fe15ac25ec5c0474193a1330a56f"><gtr:id>bd29fe15ac25ec5c0474193a1330a56f</gtr:id><gtr:otherNames>Zucchelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>MacSUQoiaE8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40D27FEB-DC1C-47D4-9946-2F9EA0979532</gtr:id><gtr:title>A plea for TDM-based optimisation for treatment of Crohn's disease - Authors' reply.</gtr:title><gtr:parentPublicationTitle>The lancet. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a8e9126a6a110.34045519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB309C36-ECD4-4540-8997-1951B7590E7F</gtr:id><gtr:title>How to Apply for and Secure EU Funding for Collaborative IBD Research Projects.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da24c4aa9fd3d3f04a822291d0cbde0"><gtr:id>5da24c4aa9fd3d3f04a822291d0cbde0</gtr:id><gtr:otherNames>Satsangi J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>56d590d59db902.37993287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19DED2BC-7AB0-40FB-AA8B-9306B9CDF767</gtr:id><gtr:title>Barrett's esophagus: evolutionary insights from genomics.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7a0fca0f1cd8e8bab752542f949f6f1"><gtr:id>d7a0fca0f1cd8e8bab752542f949f6f1</gtr:id><gtr:otherNames>Jankowski JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>545a42436180e7.64238568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB7AB901-8337-4122-BF0D-3B14293ECE90</gtr:id><gtr:title>Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>56d5905670cfd4.36847884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FD04EFA-DF83-4D62-9799-525D1DD81FCF</gtr:id><gtr:title>Letter: faecal calprotectin and lactoferrin - accurate biomarkers in post-operative Crohn's disease - authors' reply. Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - authors' reply.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc5db65cb0365641c12089dcf2c6679e"><gtr:id>cc5db65cb0365641c12089dcf2c6679e</gtr:id><gtr:otherNames>Jones GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>545a3a32cf9ea9.64343215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>006655DD-E4DA-4EA7-B237-37AC49D00F9B</gtr:id><gtr:title>Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9990519301f803df7f03605aaaeeab3"><gtr:id>b9990519301f803df7f03605aaaeeab3</gtr:id><gtr:otherNames>Huertas-Vazquez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15892_22_23593153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC48F8C6-68E0-49EC-B4B1-CCCD8EB27FB8</gtr:id><gtr:title>Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/796926032895f22b62c49cf3d20969f9"><gtr:id>796926032895f22b62c49cf3d20969f9</gtr:id><gtr:otherNames>Barton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>54648e280b1763.40215155</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FE506F2-3DBD-4E25-8705-B7CB9E6DF56D</gtr:id><gtr:title>Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>PtUMbSvWPPY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7453BA37-0645-44BF-9CB4-56D50C27F9AD</gtr:id><gtr:title>Two-stage genome-wide methylation profiling in childhood-onset Crohn's Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/046e1f58ff3098759bf68f5a319c054a"><gtr:id>046e1f58ff3098759bf68f5a319c054a</gtr:id><gtr:otherNames>Adams AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>545a39805a5ab5.89806708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38E5662F-83E8-4DE0-AFD2-88FAC360B024</gtr:id><gtr:title>Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4e64c34aaae304b77559843fb6dcff8"><gtr:id>a4e64c34aaae304b77559843fb6dcff8</gtr:id><gtr:otherNames>Travis S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>FTNa5Z8kbLx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB43F7AC-B3C8-4E31-9370-771F83FCCA23</gtr:id><gtr:title>Exploring the hidden heritability of inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da24c4aa9fd3d3f04a822291d0cbde0"><gtr:id>5da24c4aa9fd3d3f04a822291d0cbde0</gtr:id><gtr:otherNames>Satsangi J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>545a46f1843962.24061166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E799D2C-DAF9-4A35-AF92-7AF40C2C6EC3</gtr:id><gtr:title>Guidelines for the management of inflammatory bowel disease in adults.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5872a5fbb017c81d000ff8540547d87a"><gtr:id>5872a5fbb017c81d000ff8540547d87a</gtr:id><gtr:otherNames>Mowat C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>KtfRw17SVWN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F770450-94F7-4B4B-A22B-30A377079C4E</gtr:id><gtr:title>The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545a3b7bdf18e1.41628989</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFD9B0D1-7465-4DB7-B297-C7FDC6ECF40C</gtr:id><gtr:title>Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3973f4184be66ec3d0d2394aae288cc3"><gtr:id>3973f4184be66ec3d0d2394aae288cc3</gtr:id><gtr:otherNames>Cleynen I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56d59146d4a188.30542648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>215542FE-8580-4B7F-8B14-65DDE5CB0B68</gtr:id><gtr:title>Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/370760c2b2beee5cc61a02c9e4c3e85c"><gtr:id>370760c2b2beee5cc61a02c9e4c3e85c</gtr:id><gtr:otherNames>Noble CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>D14VDuf6TmE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8432E413-432B-4876-B2F8-3B570385835E</gtr:id><gtr:title>Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7cfe472cce65a6e4c1409d62261cbc1"><gtr:id>a7cfe472cce65a6e4c1409d62261cbc1</gtr:id><gtr:otherNames>Kalla R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>58b95f2c467ad5.19736272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB35BC34-F0D5-48D8-A146-A229185D7BAB</gtr:id><gtr:title>Comparison of mortality following hospitalisation for ulcerative colitis in Scotland between 1998-2000 and 2007-2009.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>545a3aa061ff96.94802206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C723E42-520D-404B-8804-34A93DA0B40F</gtr:id><gtr:title>Tuberous sclerosis-2 (TSC2) regulates the stability of death-associated protein kinase-1 (DAPK) through a lysosome-dependent degradation pathway.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df1446d37ddbc9ae923008079c6a1ce3"><gtr:id>df1446d37ddbc9ae923008079c6a1ce3</gtr:id><gtr:otherNames>Lin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>jtodYsfKA5a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA492AA0-B17F-4FDF-B8DC-49C640319577</gtr:id><gtr:title>Common variants at five new loci associated with early-onset inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a4163f30dfab1ea4a2d31101fa14e36"><gtr:id>5a4163f30dfab1ea4a2d31101fa14e36</gtr:id><gtr:otherNames>Imielinski M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>SikJJuh5Wje</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B2E4EB3-0A76-473E-8509-A001383240FE</gtr:id><gtr:title>Mass spectrometry analysis of the oxidation states of the pro-oncogenic protein anterior gradient-2 reveals covalent dimerization via an intermolecular disulphide bond.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/498e5c5e03c2f41f7b91d5f863b1ad16"><gtr:id>498e5c5e03c2f41f7b91d5f863b1ad16</gtr:id><gtr:otherNames>Clarke DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>585d533206ddc6.93037980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E50C9425-6138-4E71-832F-368B56F1C82B</gtr:id><gtr:title>Cigarette smoke extract (CSE) delays NOD2 expression and affects NOD2/RIPK2 interactions in intestinal epithelial cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f464f9e14d797f32cb291cb1c8e1802b"><gtr:id>f464f9e14d797f32cb291cb1c8e1802b</gtr:id><gtr:otherNames>Aldhous MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545a4698ae4360.09974213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F70B0E89-CA50-4B6E-B4D5-9F052DEAFBB9</gtr:id><gtr:title>Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The lancet. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5872a5fbb017c81d000ff8540547d87a"><gtr:id>5872a5fbb017c81d000ff8540547d87a</gtr:id><gtr:otherNames>Mowat C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5a8e90f207add3.89399707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91462750-3C43-430A-8817-851EC60A9A50</gtr:id><gtr:title>Can Thiopurines Prevent Formation of Antibodies Against Tumor Necrosis Factor Antagonists After Failure of These Therapies?</gtr:title><gtr:parentPublicationTitle>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1542-3565</gtr:issn><gtr:outcomeId>58b95f2b78ce47.61996198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9CCAFD0-8E56-4C56-89D9-B786DEAB7ED9</gtr:id><gtr:title>Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09cfc8db9d3df695e158267049a53fe6"><gtr:id>09cfc8db9d3df695e158267049a53fe6</gtr:id><gtr:otherNames>Flanagan PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>58b95f2f8eb030.25205860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD8F4C86-3C97-4CD7-951D-A704FB8E882F</gtr:id><gtr:title>Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34b818d5cf371312cf412804af2f7353"><gtr:id>34b818d5cf371312cf412804af2f7353</gtr:id><gtr:otherNames>Nicholls RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>ePaaFtDq1TN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7127455-D134-4767-BD18-5AB3F6DE04AC</gtr:id><gtr:title>Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8ba377304d5e7fd1f2b7d997300293a"><gtr:id>c8ba377304d5e7fd1f2b7d997300293a</gtr:id><gtr:otherNames>Nimmo ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>545a461c3108d9.10816226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EB9DF96-B035-4728-A89B-55F8CE8AF8CD</gtr:id><gtr:title>Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activity.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e504e6f1ba46486879fb5b5cedf84836"><gtr:id>e504e6f1ba46486879fb5b5cedf84836</gtr:id><gtr:otherNames>Moller FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn><gtr:outcomeId>58b95f2d5cb1c0.79881372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B185641-2753-4B42-9E40-558F306D2262</gtr:id><gtr:title>Does IBD run in families?</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58e9b7843c867fa71473bb98977691f6"><gtr:id>58e9b7843c867fa71473bb98977691f6</gtr:id><gtr:otherNames>Russell RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>54648d2d178bd2.07175087</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDDDB4DB-CF37-465C-B218-D57089368085</gtr:id><gtr:title>A Method to Exploit the Structure of Genetic Ancestry Space to Enhance Case-Control Studies.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/115678a5f93d1df09c752d1cca5b1c48"><gtr:id>115678a5f93d1df09c752d1cca5b1c48</gtr:id><gtr:otherNames>Bodea CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58b95f2d9537c6.45708707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E233BF73-576D-4E14-8E5E-77BC92251A22</gtr:id><gtr:title>Sight-threatening keratopathy complicating anti-TNF therapy in Crohn's disease: a case report.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/254011e3badfd4e4a467be550b37a45c"><gtr:id>254011e3badfd4e4a467be550b37a45c</gtr:id><gtr:otherNames>Fasci-Spurio F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>545a3bc397d523.29043370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>691EE1C1-B1DF-471C-A972-0D0A2D18C860</gtr:id><gtr:title>Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e6243a98509e54910c6932cb74b8db"><gtr:id>50e6243a98509e54910c6932cb74b8db</gtr:id><gtr:otherNames>Lee JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_15892_22_24035192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41119F36-51A8-495C-8FA6-20DFE8E825C5</gtr:id><gtr:title>New IBD genetics: common pathways with other diseases.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>daGJcP4s521</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0065770C-35B1-46B4-AF7E-577A3CA1605F</gtr:id><gtr:title>Genetics of childhood-onset inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>iLs6pZmcL7k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CBEA8BC-42EE-48BB-B608-021BE8A9FE9D</gtr:id><gtr:title>MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f42b266fd11aa87e2c88a384ee9d26"><gtr:id>64f42b266fd11aa87e2c88a384ee9d26</gtr:id><gtr:otherNames>Ho GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5a3068d0a40373.77821407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F9D2AE5-A8DC-414A-95C4-280E0DBE06CF</gtr:id><gtr:title>Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f464f9e14d797f32cb291cb1c8e1802b"><gtr:id>f464f9e14d797f32cb291cb1c8e1802b</gtr:id><gtr:otherNames>Aldhous MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>eCiPTvpufSX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84B67514-A71D-4795-94F8-0F9D030D6B82</gtr:id><gtr:title>Autophagy: from basic science to clinical application.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>sMDWG6BPA2d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1ADC18B-DE32-4303-8A3F-F5E29B66DEA9</gtr:id><gtr:title>Variation in ICOSLG influences Crohn's disease susceptibility.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>X8DpX18JEuU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24CBE91E-B644-4376-A0D4-9E403AC76578</gtr:id><gtr:title>Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64f42b266fd11aa87e2c88a384ee9d26"><gtr:id>64f42b266fd11aa87e2c88a384ee9d26</gtr:id><gtr:otherNames>Ho GT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>54648b953c9942.46219440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21E9A165-A53C-4942-AC37-9308919DCAB3</gtr:id><gtr:title>Characterisation of osteoprotegerin autoantibodies in coeliac disease.</gtr:title><gtr:parentPublicationTitle>Calcified tissue international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8924067a61debc954d4516114f2908a2"><gtr:id>8924067a61debc954d4516114f2908a2</gtr:id><gtr:otherNames>Real A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0171-967X</gtr:issn><gtr:outcomeId>58b95f2f11e9b3.25352146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE08D9F9-913B-443A-AD88-97FCD167D720</gtr:id><gtr:title>A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bd098697bd70f44f21e158259d0b6f4"><gtr:id>1bd098697bd70f44f21e158259d0b6f4</gtr:id><gtr:otherNames>Rivas MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a8e933c5452b7.53754809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B68994F-C02F-4D7E-BDAF-FFA3B6022D23</gtr:id><gtr:title>Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d48c2365018bf37692689d84ad467a48"><gtr:id>d48c2365018bf37692689d84ad467a48</gtr:id><gtr:otherNames>Beaudoin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_15892_22_24068945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C8178DF-F74B-451F-8365-7852FA5B61DA</gtr:id><gtr:title>Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial.</gtr:title><gtr:parentPublicationTitle>The lancet. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b286adc1a9b5cef514339bc18c7d9a29"><gtr:id>b286adc1a9b5cef514339bc18c7d9a29</gtr:id><gtr:otherNames>Lindsay JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a8e90be126d84.73155277</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A8319D6-BD03-495D-BAFD-BD0EF5908987</gtr:id><gtr:title>Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>58b95f2ec62925.28949032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35F4DF1E-5C73-4823-BF78-E387C58CFD7F</gtr:id><gtr:title>Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec6d3af19cb069864e282d238103313e"><gtr:id>ec6d3af19cb069864e282d238103313e</gtr:id><gtr:otherNames>Chen GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>545a3b0b25c404.00893706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2CA42F8-59A0-4791-9831-585E61EEA875</gtr:id><gtr:title>Resolution of non-small-cell lung cancer after withdrawal of anti-TNF therapy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>NUUVMrJXDjf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10F3926B-4643-4ED0-970F-819CE65F3DFA</gtr:id><gtr:title>pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19956025010c7cc0e142741034f526e9"><gtr:id>19956025010c7cc0e142741034f526e9</gtr:id><gtr:otherNames>Birimberg-Schwartz L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>585d67728b7d37.78571609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F072C51-E940-4D70-9337-8513595E4B5C</gtr:id><gtr:title>Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08112693a12b70debb270f3297d29147"><gtr:id>08112693a12b70debb270f3297d29147</gtr:id><gtr:otherNames>Fisher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>RoPRWkR91YN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC4C2803-B3E0-4CA2-B0DA-2E1C69C0654F</gtr:id><gtr:title>Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bd098697bd70f44f21e158259d0b6f4"><gtr:id>1bd098697bd70f44f21e158259d0b6f4</gtr:id><gtr:otherNames>Rivas MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a8e92efe6ad26.34012146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BF49908-5EF1-4BD6-9953-09A997B07879</gtr:id><gtr:title>The role of glycosylation in IBD.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddf6086ff1060ed1c3c1158b9e0085f5"><gtr:id>ddf6086ff1060ed1c3c1158b9e0085f5</gtr:id><gtr:otherNames>Theodoratou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-5045</gtr:issn><gtr:outcomeId>545a3a6f3ff890.55433425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C42A0B65-42DC-4439-BB96-552316D365BF</gtr:id><gtr:title>Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3879ad10d1bd3ea7bcc9795bbb0ad5d6"><gtr:id>3879ad10d1bd3ea7bcc9795bbb0ad5d6</gtr:id><gtr:otherNames>Orozco G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>546386df888ab4.97374845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0F7DCD0-30F3-4250-8DCC-0858A580267A</gtr:id><gtr:title>Multiple sclerosis in the context of TNF blockade and inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33800cbdd8ec2b7e624dd14dad808264"><gtr:id>33800cbdd8ec2b7e624dd14dad808264</gtr:id><gtr:otherNames>Hare NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>pm_15892_22_22240391</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEAD105D-E253-4547-BCBE-C8003ED182CF</gtr:id><gtr:title>Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17620d321d3b329acfee3c0bd6e3632c"><gtr:id>17620d321d3b329acfee3c0bd6e3632c</gtr:id><gtr:otherNames>Quince C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>585d561ba164b0.09534919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCFAE98D-B60B-45ED-BD3E-4FFE1602DCF8</gtr:id><gtr:title>Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1605ad728ecb6d5cabf79b7add99fc60"><gtr:id>1605ad728ecb6d5cabf79b7add99fc60</gtr:id><gtr:otherNames>Li YR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>56d591e6bb3c07.67674905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>456F9FE8-A421-41AB-8E61-020FD9093C50</gtr:id><gtr:title>Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e6243a98509e54910c6932cb74b8db"><gtr:id>50e6243a98509e54910c6932cb74b8db</gtr:id><gtr:otherNames>Lee JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a8e918e77fa38.23245314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B258BDF7-0C15-4C31-9A2D-9C2442E424C0</gtr:id><gtr:title>Therapeutic options in acute severe ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Expert review of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33800cbdd8ec2b7e624dd14dad808264"><gtr:id>33800cbdd8ec2b7e624dd14dad808264</gtr:id><gtr:otherNames>Hare NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1747-4124</gtr:issn><gtr:outcomeId>it4REmLPQrU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01F3A0F3-6BFA-467A-BBE2-7951C712EA3F</gtr:id><gtr:title>Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8e45c11ff8b196523502e41d8ce46cf"><gtr:id>c8e45c11ff8b196523502e41d8ce46cf</gtr:id><gtr:otherNames>Anderson CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>FSDmJt2LES7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>790766C0-8DEF-4C95-8781-37EAF0AA5873</gtr:id><gtr:title>Does nicotine influence cytokine profile and subsequent cell cycling/apoptotic responses in inflammatory bowel disease?</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f464f9e14d797f32cb291cb1c8e1802b"><gtr:id>f464f9e14d797f32cb291cb1c8e1802b</gtr:id><gtr:otherNames>Aldhous MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>54648f4c930014.41844100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DA746DF-005C-4150-AC9F-927F62AFF5E9</gtr:id><gtr:title>Nationwide linkage analysis in Scotland-Has mortality following hospital admission for Crohn's disease changed in the early 21st century?</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>545a3912d32900.39914675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39E50E9F-4ADF-479C-98C8-D59DE14CBBCB</gtr:id><gtr:title>Copy number variation of scavenger-receptor cysteine-rich domains within DMBT1 and Crohn's disease.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8572e735ea379400c17eb20c116ef05a"><gtr:id>8572e735ea379400c17eb20c116ef05a</gtr:id><gtr:otherNames>Polley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>58b95f2e776cc6.58148849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79E2C5D1-658F-4554-A288-170D18C66B8C</gtr:id><gtr:title>A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>pm_15892_22_24117596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A6F7A4A-6477-4DCA-9777-855AA9CEFB76</gtr:id><gtr:title>Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ba4484ccc898295a012002024ec60c3"><gtr:id>8ba4484ccc898295a012002024ec60c3</gtr:id><gtr:otherNames>de Lange KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b95f2b3746f1.38171809</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600329</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>